Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2017-03-09

FDA Approved: VORICONAZOLE — Original Application (Xellia Pharmaceuticals USA LLC)

View source ↗

Summary

FDA approved voriconazole via an Original Application submitted by Xellia Pharmaceuticals USA LLC (NDA208562).

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • VORICONAZOLE (Voriconazole)

Snippet

ORIG AP for VORICONAZOLE (VORICONAZOLE)